Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Plasma selenium levels and the risk of colorectal adenomas.

Russo MW, Murray SC, Wurzelmann JI, Woosley JT, Sandler RS.

Nutr Cancer. 1997;28(2):125-9.

PMID:
9290116
2.

Micronutrients and the risk of colorectal adenomas.

Tseng M, Murray SC, Kupper LL, Sandler RS.

Am J Epidemiol. 1996 Dec 1;144(11):1005-14. Erratum in: Am J Epidemiol 1997 Nov 1;146(9):788.

PMID:
8942430
3.

Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status.

Fernández-Bañares F, Cabré E, Esteve M, Mingorance MD, Abad-Lacruz A, Lachica M, Gil A, Gassull MA.

Am J Gastroenterol. 2002 Aug;97(8):2103-8.

PMID:
12190184
4.

Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study.

Wallace K, Byers T, Morris JS, Cole BF, Greenberg ER, Baron JA, Gudino A, Spate V, Karagas MR.

Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):464-7.

5.

Selenium and colorectal adenoma: results of a pooled analysis.

Jacobs ET, Jiang R, Alberts DS, Greenberg ER, Gunter EW, Karagas MR, Lanza E, Ratnasinghe L, Reid ME, Schatzkin A, Smith-Warner SA, Wallace K, Martínez ME.

J Natl Cancer Inst. 2004 Nov 17;96(22):1669-75.

PMID:
15547179
6.

Serum selenium and colonic neoplastic risk.

Nelson RL, Davis FG, Sutter E, Kikendall JW, Sobin LH, Milner JA, Bowen PE.

Dis Colon Rectum. 1995 Dec;38(12):1306-10.

PMID:
7497844
7.

Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.

Sandler RS, Galanko JC, Murray SC, Helm JF, Woosley JT.

Gastroenterology. 1998 Mar;114(3):441-7.

PMID:
9496933
8.

Selenium, apoptosis, and colorectal adenomas.

Connelly-Frost A, Poole C, Satia JA, Kupper LL, Millikan RC, Sandler RS.

Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):486-93.

9.

Selenium and colorectal adenomas risk: a meta-analysis.

Ou Y, Jiang B, Wang X, Ma W, Guo J.

Nutr Cancer. 2012;64(8):1153-9. doi: 10.1080/01635581.2012.722248.

PMID:
23163843
10.

Do we need colonoscopy in patients with gastric adenomas? The risk of colorectal adenoma in patients with gastric adenomas.

Yang MH, Son HJ, Lee JH, Kim MH, Kim JY, Kim YH, Chang DK, Rhee PL, Kim JJ, Rhee JC.

Gastrointest Endosc. 2010 Apr;71(4):774-81. doi: 10.1016/j.gie.2009.11.042.

PMID:
20363417
11.

Insulin resistance, apoptosis, and colorectal adenoma risk.

Keku TO, Lund PK, Galanko J, Simmons JG, Woosley JT, Sandler RS.

Cancer Epidemiol Biomarkers Prev. 2005 Sep;14(9):2076-81.

12.

Risk factors for advanced colorectal adenomas: a pooled analysis.

Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Fenoglio-Preiser CM, Potter JD.

Cancer Epidemiol Biomarkers Prev. 2002 Jul;11(7):622-9.

13.

A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer.

Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R.

N Engl J Med. 2003 Mar 6;348(10):883-90. Erratum in: N Engl J Med. 2003 May 8;348(19):1939.

14.

Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia.

Whelan RL, Horvath KD, Gleason NR, Forde KA, Treat MD, Teitelbaum SL, Bertram A, Neugut AI.

Dis Colon Rectum. 1999 Feb;42(2):212-7.

PMID:
10211498
15.

C-reactive protein and colorectal adenomas: Self Defense Forces Health Study.

Otake T, Uezono K, Takahashi R, Fukumoto J, Tabata S, Abe H, Tajima O, Mizoue T, Ohnaka K, Kono S.

Cancer Sci. 2009 Apr;100(4):709-14.

PMID:
19469014
16.

Hormone replacement therapy and colorectal adenoma recurrence among women in the Polyp Prevention Trial.

Woodson K, Lanza E, Tangrea JA, Albert PS, Slattery M, Pinsky J, Caan B, Paskett E, Iber F, Kikendall JW, Lance P, Shike M, Weissfeld J, Schatzkin A.

J Natl Cancer Inst. 2001 Dec 5;93(23):1799-805.

PMID:
11734596
17.

Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.

Baron JA, Beach M, Mandel JS, van Stolk RU, Haile RW, Sandler RS, Rothstein R, Summers RW, Snover DC, Beck GJ, Bond JH, Greenberg ER.

N Engl J Med. 1999 Jan 14;340(2):101-7.

18.

Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network.

Alberts DS, Martínez ME, Roe DJ, Guillén-Rodríguez JM, Marshall JR, van Leeuwen JB, Reid ME, Ritenbaugh C, Vargas PA, Bhattacharyya AB, Earnest DL, Sampliner RE.

N Engl J Med. 2000 Apr 20;342(16):1156-62.

19.

Plasma enterolignans are associated with lower colorectal adenoma risk.

Kuijsten A, Arts IC, Hollman PC, van't Veer P, Kampman E.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1132-6.

20.

Dietary intake of heterocyclic amines, meat-derived mutagenic activity, and risk of colorectal adenomas.

Sinha R, Kulldorff M, Chow WH, Denobile J, Rothman N.

Cancer Epidemiol Biomarkers Prev. 2001 May;10(5):559-62.

Supplemental Content

Support Center